Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1Unknown 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Ovarian Neoplasms 13Endometrial Neoplasms 4Carcinoma, Ovarian Epithelial 4Breast Neoplasms 4Neoplasms 3Uterine Neoplasms 2Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Recurrence 2Prostatic Neoplasms 2Lung Neoplasms 2Esophageal Neoplasms 2Carcinoma, Renal Cell 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Thyroid Neoplasms 1Stomach Neoplasms 1Ovarian Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms by Site 1Neoplasms by Histologic Type 1Melanoma 1Laryngeal Neoplasms 1Kenny-Caffey syndrome, Type 1 1Hyperglycemia 1High Grade Serous Ovarian Cancer 1Head and Neck Neoplasms 1Genital Neoplasms, Female 1Genital Diseases, Female 1Fallopian Tube Neoplasms 1

Interventions

Cisplatin 10Paclitaxel 9Radiotherapy 5Fluorouracil 5Radiotherapy, Intensity-Modulated 4Docetaxel 4Carboplatin 4advexin 2Therapeutics 2Surveys and Questionnaires 2Oxaliplatin 2Leucovorin 2Drug Therapy 2Cetuximab 2Afatinib 2penpulimab 1pembrolizumab 1olaparib 1niraparib 1nimotuzumab 1nedaplatin 1durvalumab 1daromun 1camrelizumab 1calcipotriene 1atezolizumab 1afamelanotide 1TP protocol 1Surgical Procedures, Operative 1Radiotherapy, Adjuvant 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Squamous Cell × olaparib × Clear all
NCT02229656 2023-11-07

Olaparib and Radiotherapy in Head and Neck Cancer

The Netherlands Cancer Institute

Phase 1 Unknown
12 enrolled
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡